The Proliferation–Invasion Dichotomy: Transcriptomic Signatures of lncRNA and Ubiquitin–Proteasome Networks in Hypermutated Endometrial Cancer
9 affiliations
- 1Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, Hospital da Luz Lisboa, Luz Saúde, Avenida Lusíada 100, 1500-650 Lisboa, Portugal
- 2Unit of Gynecology and Obstetrics, Department of Women and Children, University of Padua, 35122 Padua, Italy
- 3Department of Pathology, Hospital da Luz Lisboa, Luz Saúde, Avenida Lusíada 100, 1500-650 Lisboa, Portugal
- 4Católica Biomedical Research Centre, Faculdade de Medicina, Universidade Católica Portuguesa, 2780-156 Oeiras, Portugal
- 5Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, 1275 York Avenue, New York, NY 10065, USA
- 6Hospital da Luz Learning Health, Luz Saúde, Avenida Lusíada 100, 1500-650 Lisboa, Portugal
- 7iNOVA4Health, NOVA Medical School, Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, 1169-056 Lisboa, Portugal
- 8Department of Obstetrics and Gynecology, Hospital da Luz Lisboa, Luz Saúde, Avenida Lusíada 100, 1500-650 Lisboa, Portugal
- 9Comprehensive Health Research Centre (CHRC), NOVA Medical School (NMS), Universidade NOVA de Lisboa, Campo Mártires da Pátria, 130, 1169-056 Lisboa, Portugal
Abstract
Endometrial cancer incidence is markedly rising globally, posing an urgent need to elucidate the molecular mechanisms driving disease characterization and progression. Endometrial cancer evolution is driven by canonical Wnt and p53 pathway alterations, yet the mechanisms orchestrating the transition from localized proliferation to stromal invasion, the proliferation–invasion dichotomy, remain poorly understood. While long non-coding RNAs (lncRNAs) are emerging as critical correlates of divergent tumor phenotypes, their coordination with the broader ubiquitin–proteasome system (UPS), specifically E3 ligase and deubiquitinase (DUB) networks, during endometrial cancer progression is largely unexplored. Whole-transcriptome RNA sequencing was performed on formalin-fixed paraffin-embedded (FFPE) tissue from a clinical cohort of 38 patients, comprising 34 primary endometrial carcinomas across distinct molecular subtypes (MSI, POLE, p53abn, and NSMP) and four pre-cancerous endometrial intraepithelial neoplasia (EIN) lesions. To stringently control for baseline patient-specific confounding, differential gene expression and principal component analyses were executed using a strict, intra-patient, matched-pair design (Tumor vs. Adjacent Normal). A principal component analysis of the batch-corrected transcriptome revealed a profound divergence between tumor and paired adjacent normal phenotypes. This spatial divergence was heavily characterized by lncRNA signatures (including SOCS2-AS1) strongly associated with extracellular matrix (ECM) remodeling. Concurrently, we identified a critical, malignancy-specific transcriptomic dysregulation across the broader UPS network. Within this altered transcriptional landscape, the ubiquitin C-terminal hydrolase (UCHL) family emerged as a highly significant node. UCHL5 displayed robust, global upregulation across the pan-cancer cohort compared with matched controls (log2FC = 0.83, padj < 0.001). Strikingly, UCHL3 exhibited global upregulation (log2FC = 1.23, padj = 0.002) that was highly concentrated within the microsatellite instability (MSI) and polymerase epsilon (POLE) hypermutated subtypes, highlighting a potential compensatory transcriptomic response to the predicted cellular stress inherent to high mutational burdens. In an exploratory subset of pre-cancerous EIN lesions (n = 4), neither the invasive lncRNA networks nor profound UPS/UCHL dysregulation were observed, suggesting a preliminary trend that requires validation in larger precursor cohorts. Our paired transcriptomic mapping reveals that endometrial cancer progression is characterized by divergent transcriptomic programs: specific lncRNA networks are tightly coupled to the invasive remodeling of the ECM, while concurrent dysregulation of broad UPS networks reflects the altered proteostasis associated with this phenotypic shift. The pronounced upregulation of critical UPS nodes, such as UCHL3 in MSI/POLE tumors, highlights a landscape of novel, enzymatically targetable vulnerabilities in hypermutated endometrial cancers.
Related
- Transcriptomic Reproducibility in Endometrial Biopsies: Evidence Across Cycles and Tissue Regions in Hormonal Replacement Therapy Endometrial Preparation Protocols
- Identification and validation of T cell proliferation-associated transcriptomic biomarkers in ischemic stroke
- Nutrition-related lipid metabolism and ferroptosis in endometrial cancer: transcriptomic profiling and hypoxia-associated gene expression
- Nicotinamide Mononucleotide Is Associated with Attenuation of OGD/R-Induced Pro-Inflammatory Programs in Microglia: Transcriptomic Evidence Converging on the NLRP3 Inflammasome and Lipid-Droplet-Related Molecular Signatures
- Primary-Tumor Transcriptomic Signatures Associated with Circulating Tumor Cells Status in Breast Cancer: From CTC-Negative Remodeling to CTC-Associated Metastatic Programs
BibTeX
@article{casanova2026proliferationinvasion,
title = {{The Proliferation–Invasion Dichotomy: Transcriptomic Signatures of lncRNA and Ubiquitin–Proteasome Networks in Hypermutated Endometrial Cancer}},
author = {João Casanova and Ana Gomes da Costa and Marta Tripepi and Ana Pestana and Ana Catarino and Nélson Martins and Luís Teixeira and Nadeem Abu-Rustum and Rita Rosado-Ramos and Rune Matthiensen and Jorge Lima},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = oct,
doi = {10.3390/ijms27208954},
url = {https://www.mdpi.com/1422-0067/27/20/8954},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The Proliferation–Invasion Dichotomy: Transcriptomic Signatures of lncRNA and Ubiquitin–Proteasome Networks in Hypermutated Endometrial Cancer
AU - João Casanova
AU - Ana Gomes da Costa
AU - Marta Tripepi
AU - Ana Pestana
AU - Ana Catarino
AU - Nélson Martins
AU - Luís Teixeira
AU - Nadeem Abu-Rustum
AU - Rita Rosado-Ramos
AU - Rune Matthiensen
AU - Jorge Lima
PY - 2026
DA - 2026/10/09
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms27208954
UR - https://www.mdpi.com/1422-0067/27/20/8954
AB - Endometrial cancer incidence is markedly rising globally, posing an urgent need to elucidate the molecular mechanisms driving disease characterization and progression. Endometrial cancer evolution is driven by canonical Wnt and p53 pathway alterations, yet the mechanisms orchestrating the transition from localized proliferation to stromal invasion, the proliferation–invasion dichotomy, remain poorly understood. While long non-coding RNAs (lncRNAs) are emerging as critical correlates of divergent tumor phenotypes, their coordination with the broader ubiquitin–proteasome system (UPS), specifically E3 ligase and deubiquitinase (DUB) networks, during endometrial cancer progression is largely unexplored. Whole-transcriptome RNA sequencing was performed on formalin-fixed paraffin-embedded (FFPE) tissue from a clinical cohort of 38 patients, comprising 34 primary endometrial carcinomas across distinct molecular subtypes (MSI, POLE, p53abn, and NSMP) and four pre-cancerous endometrial intraepithelial neoplasia (EIN) lesions. To stringently control for baseline patient-specific confounding, differential gene expression and principal component analyses were executed using a strict, intra-patient, matched-pair design (Tumor vs. Adjacent Normal). A principal component analysis of the batch-corrected transcriptome revealed a profound divergence between tumor and paired adjacent normal phenotypes. This spatial divergence was heavily characterized by lncRNA signatures (including SOCS2-AS1) strongly associated with extracellular matrix (ECM) remodeling. Concurrently, we identified a critical, malignancy-specific transcriptomic dysregulation across the broader UPS network. Within this altered transcriptional landscape, the ubiquitin C-terminal hydrolase (UCHL) family emerged as a highly significant node. UCHL5 displayed robust, global upregulation across the pan-cancer cohort compared with matched controls (log2FC = 0.83, padj < 0.001). Strikingly, UCHL3 exhibited global upregulation (log2FC = 1.23, padj = 0.002) that was highly concentrated within the microsatellite instability (MSI) and polymerase epsilon (POLE) hypermutated subtypes, highlighting a potential compensatory transcriptomic response to the predicted cellular stress inherent to high mutational burdens. In an exploratory subset of pre-cancerous EIN lesions (n = 4), neither the invasive lncRNA networks nor profound UPS/UCHL dysregulation were observed, suggesting a preliminary trend that requires validation in larger precursor cohorts. Our paired transcriptomic mapping reveals that endometrial cancer progression is characterized by divergent transcriptomic programs: specific lncRNA networks are tightly coupled to the invasive remodeling of the ECM, while concurrent dysregulation of broad UPS networks reflects the altered proteostasis associated with this phenotypic shift. The pronounced upregulation of critical UPS nodes, such as UCHL3 in MSI/POLE tumors, highlights a landscape of novel, enzymatically targetable vulnerabilities in hypermutated endometrial cancers.
SN - 1422-0067
ER -